Nifty
Sensex
:
:
11483.25
38233.41
129.00 (1.14%)
424.50 (1.12%)

Pharmaceuticals & Drugs

Rating :
67/99

BSE: 524742 | NSE: CAPLIPOINT

401.70
-4.40 (-1.08%)
26-Mar-2019 | 3:51PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  414.00
  •  414.00
  •  401.00
  •  406.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14660
  •  58.89
  •  623.00
  •  296.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,041.85
  • 18.76
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,963.11
  • 0.50%
  • 6.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.05%
  • 1.89%
  • 17.60%
  • FII
  • DII
  • Others
  • 0.03%
  • 0.00%
  • 11.43%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 31.26

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.92

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 46.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.65
  • 32.06
  • 32.28

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.29
  • 13.73
  • 13.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.53
  • 21.49
  • 22.38

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
159.03
141.61
12.30%
155.86
131.31
18.70%
146.46
123.51
18.58%
143.41
118.06
21.47%
Expenses
101.27
90.82
11.51%
100.08
81.95
22.12%
93.43
77.61
20.38%
94.69
74.83
26.54%
EBITDA
57.76
50.79
13.72%
55.78
49.36
13.01%
53.03
45.90
15.53%
48.72
43.22
12.73%
EBIDTM
36.32%
35.87%
35.79%
37.59%
36.21%
37.16%
33.97%
36.61%
Other Income
7.74
2.33
232.19%
7.01
3.58
95.81%
1.61
3.86
-58.29%
2.90
4.38
-33.79%
Interest
0.02
0.02
0.00%
0.02
0.02
0.00%
0.01
0.02
-50.00%
0.01
0.02
-50.00%
Depreciation
5.67
4.53
25.17%
5.58
4.45
25.39%
5.45
3.85
41.56%
6.18
4.99
23.85%
PBT
59.81
48.58
23.12%
57.20
48.47
18.01%
49.17
45.90
7.12%
45.43
42.59
6.67%
Tax
14.00
11.10
26.13%
13.70
12.94
5.87%
11.78
9.58
22.96%
10.13
9.27
9.28%
PAT
45.81
37.48
22.23%
43.50
35.54
22.40%
37.39
36.33
2.92%
35.29
33.32
5.91%
PATM
28.80%
26.47%
27.91%
27.06%
25.53%
29.41%
24.61%
28.23%
EPS
6.06
4.97
21.93%
5.75
4.71
22.08%
4.95
4.81
2.91%
4.68
4.42
5.88%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Net Sales
604.76
539.84
401.65
238.72
251.77
173.09
127.03
107.22
80.78
Net Sales Growth
17.55%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
32.73%
 
Cost Of Goods Sold
264.77
238.18
184.93
121.16
135.62
102.58
84.45
77.36
60.88
Gross Profit
339.99
301.66
216.72
117.56
116.15
70.50
42.58
29.85
19.89
GP Margin
56.22%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
24.62%
Total Expenditure
389.47
344.52
276.84
174.51
192.06
136.90
104.68
96.06
71.58
Power & Fuel Cost
-
10.98
9.91
7.56
8.61
3.07
1.12
0.84
0.68
% Of Sales
-
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
0.84%
Employee Cost
-
37.61
29.71
17.92
18.24
12.63
7.69
6.28
4.14
% Of Sales
-
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
5.13%
Manufacturing Exp.
-
37.11
28.56
14.33
16.04
7.42
3.07
1.63
1.54
% Of Sales
-
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
1.91%
General & Admin Exp.
-
14.54
13.78
8.15
7.97
6.54
4.67
3.58
3.00
% Of Sales
-
2.69%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
3.71%
Selling & Distn. Exp.
-
6.01
9.41
2.29
2.85
1.46
1.02
0.91
0.67
% Of Sales
-
1.11%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
0.83%
Miscellaneous Exp.
-
0.10
0.55
3.10
2.72
3.19
2.66
5.44
0.66
% Of Sales
-
0.02%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
0.82%
EBITDA
215.29
195.32
124.81
64.21
59.71
36.19
22.35
11.16
9.20
EBITDA Margin
35.60%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
11.39%
Other Income
19.26
12.67
9.96
3.66
3.03
3.72
2.10
2.51
2.55
Interest
0.06
0.61
0.52
0.34
0.97
0.68
0.77
1.26
1.20
Depreciation
22.88
19.00
13.30
7.48
8.38
3.54
1.54
1.24
2.32
PBT
211.61
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Tax
49.61
43.74
25.44
14.28
12.26
9.76
8.12
3.14
1.91
Tax Rate
23.44%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
23.24%
PAT
161.99
144.78
95.61
45.77
41.04
25.85
13.98
8.01
6.28
PAT before Minority Interest
162.12
144.63
95.50
45.77
41.13
25.93
14.02
8.03
6.31
Minority Interest
0.13
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
-0.03
PAT Margin
26.79%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
7.77%
PAT Growth
13.54%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
27.55%
 
Unadjusted EPS
21.44
19.26
12.65
30.28
27.16
17.11
9.25
5.30
4.16

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Shareholder's Funds
363.83
224.76
128.14
93.19
61.74
43.14
33.58
29.08
Share Capital
15.12
15.12
15.11
15.11
15.11
15.11
15.11
15.11
Total Reserves
345.42
209.56
111.40
78.08
46.63
28.03
18.47
13.97
Non-Current Liabilities
27.86
19.90
13.69
10.39
10.42
8.66
4.29
1.82
Secured Loans
0.32
0.48
0.73
0.88
2.07
3.48
1.55
0.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.40
1.63
0.82
0.81
0.38
0.27
0.20
Current Liabilities
108.67
113.36
125.04
124.97
107.58
83.01
69.20
40.44
Trade Payables
94.23
78.60
55.71
41.56
31.50
25.64
21.26
17.06
Other Current Liabilities
12.66
33.09
60.39
72.11
66.42
50.85
38.33
10.71
Short Term Borrowings
0.00
0.00
0.00
0.05
0.05
0.05
5.20
9.46
Short Term Provisions
1.78
1.67
8.94
11.25
9.60
6.47
4.41
3.22
Total Liabilities
500.45
358.38
267.14
228.82
179.92
134.90
107.12
71.37
Net Block
169.48
151.83
144.23
113.13
102.24
32.71
27.54
24.95
Gross Block
231.79
195.15
180.76
142.71
123.06
50.06
43.36
39.53
Accumulated Depreciation
62.31
43.31
36.53
29.58
20.82
17.36
15.82
14.58
Non Current Assets
237.46
179.16
148.61
146.95
131.30
96.21
53.41
30.12
Capital Work in Progress
15.29
3.42
0.23
30.63
24.54
48.98
12.79
0.17
Non Current Investment
41.45
13.24
0.44
0.45
0.44
1.19
1.14
1.15
Long Term Loans & Adv.
11.23
10.67
3.71
2.75
3.67
10.83
11.94
3.85
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
263.00
179.22
118.53
81.87
48.61
38.70
53.71
41.25
Current Investments
5.22
4.20
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
28.46
22.29
18.81
13.66
9.79
10.42
6.38
5.50
Sundry Debtors
125.88
33.02
7.95
5.66
0.09
0.86
7.28
8.33
Cash & Bank
79.28
93.07
68.10
45.37
26.82
16.84
31.80
21.62
Other Current Assets
24.16
7.32
11.09
6.10
11.90
10.57
8.25
5.80
Short Term Loans & Adv.
17.28
19.31
12.58
11.08
8.16
5.61
4.50
3.44
Net Current Assets
154.33
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
0.81
Total Assets
500.46
358.38
267.14
228.82
179.91
134.91
107.12
71.37

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Cash From Operating Activity
66.48
67.61
42.40
49.88
59.83
31.95
27.92
14.25
PBT
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Adjustment
14.83
8.61
3.87
6.21
2.14
-0.21
-0.25
2.06
Changes in Working Capital
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
4.49
Cash after chg. in Working capital
102.83
91.16
58.78
61.56
67.15
37.75
29.81
14.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
-0.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
-6.90
Net Fixed Assets
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
-0.37
Net Cash Inflow / Outflow
-14.14
24.76
22.73
18.55
9.99
-14.97
10.18
6.98
Opening Cash & Equivalents
91.31
66.55
45.37
26.82
16.84
31.80
21.62
14.64
Closing Cash & Equivalent
77.17
91.31
68.10
45.37
26.82
16.84
31.80
21.62

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Book Value (Rs.)
47.69
29.73
16.25
11.84
7.68
5.22
3.95
3.36
ROA
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
8.84%
ROE
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
24.90%
ROCE
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
26.87%
Fixed Asset Turnover
2.53
2.14
1.48
1.89
2.00
2.73
2.61
2.04
Receivable days
53.72
18.62
10.40
4.17
1.00
11.66
26.30
37.63
Inventory Days
17.16
18.68
24.83
17.00
21.31
24.06
20.01
24.84
Payable days
89.66
88.17
103.48
69.75
79.69
85.60
79.07
88.42
Cash Conversion Cycle
-18.78
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
-25.95
Total Debt/Equity
0.00
0.00
0.02
0.02
0.06
0.12
0.23
0.38
Interest Cover
309.72
235.08
179.35
56.11
53.29
29.73
9.88
7.84

Top Investors:

News Update:


  • Caplin Point Laboratories’ arm gets USFDA’s nod for Glycopyrrolate injection
    22nd Mar 2019, 14:12 PM

    Glycopyrrolate had US sales data of approximately $110.12 Million for the 12 month period ending December 2018

    Read More
  • Caplin Point Lab - Quarterly Results
    11th Feb 2019, 13:43 PM

    Read More
  • Caplin Point Laboratories planning to enter in business transfer agreement
    2nd Jan 2019, 10:32 AM

    The meeting of the Board of Directors of the Company is scheduled to be held on January 11, 2019, to consider the same

    Read More
  • Caplin Point Laboratories incorporates Wholly Owned Subsidiary
    17th Dec 2018, 14:09 PM

    The Certificate of Incorporation was received by the Company on December 14, 2018

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.